Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
PLoS One ; 11(12): e0168559, 2016.
Article in English | MEDLINE | ID: mdl-28033402

ABSTRACT

BACKGROUND: Tuberculosis and HIV remain a public health problem in developed countries. The objective of this study was to analyze the incidence trends of pulmonary TB and HIV comorbidity and treatment outcomes according to HIV during the period 2006 to 2014 in the Mexican Institute of Social Security. METHODS: Analyzed data from this registry including pulmonary tuberculosis patients aged 15 years and older who had been diagnosed during the years 2006 to 2014 in the Mexican Institute of Social Security. The outcomes that we use were incidents rate, failure to treatment and death. Regression models were used to quantify associations between pulmonary tuberculosis and HIV mortality. RESULTS: During the study period, 31,352 patients were registered with pulmonary tuberculosis. The incidence rate observed during 2014 was 11.6 case of PTB per 100,000. The incidence rate for PTB and HIV was 0.345 per 100,000. The PTB incidence rate decreased by 0.07%, differences found in the PTB incidence rate by sex since in women decreased by 5.52% and in man increase by 3.62%. The pulmonary TB with HIV incidence rate decreased by 16.3% during the study period (In women increase 4.81% and in man decrease 21.6%). Analysis of PTB associated with HIV by age groups revealed that the highest incidence rates were observed for the 30 to 44 years old group. Meanwhile, the highest incidence rates of PTB without HIV occurred among the 60 and more years old individuals. We did not find statistically significant differences between treatment failure and PTB patients with HIV and without HIV. The treatment failure was associated with sex and the region of the patient. We found a strong association between HIV and the probability of dying during treatment. Our data suggested that patients suffering from both conditions (PTB and HIV) have no difference in the probability of failure of treatment contrary to other reports. Hypotheses to this is adherence to tuberculosis treatment with people living with HIV/AIDS, detection of PTB in patients suffering from HIV/AIDS or PTB patients on antiretroviral therapy were more likely to have successful treatment outcomes than those not on antiretroviral treatment. We have found that PTB and HIV increases the probability of dying during treatment compared to the cases of PTB without HIV, consistent with published other study HIV increases the mortality rates associated with PTB. CONCLUSIONS: No association between pulmonary tuberculosis with HIV and treatment failure was observed, but pulmonary tuberculosis and HIV increases the probability of dying during treatment compared to the pulmonary tuberculosis cases without HIV.


Subject(s)
HIV Infections/epidemiology , Social Security , Tuberculosis, Pulmonary/epidemiology , Adolescent , Adult , Aged , Comorbidity , Female , Humans , Male , Mexico/epidemiology , Middle Aged , Registries , Retrospective Studies , Young Adult
2.
Rev Med Inst Mex Seguro Soc ; 54(1): 20-4, 2016.
Article in Spanish | MEDLINE | ID: mdl-26820194

ABSTRACT

BACKGROUND: The prevention and control of the nosocomial infections involve the knowledge of the most frequent type of microorganism isolated. In Mexico there are not national statistics to identify the main microorganisms that cause a nosocomial infection. METHODS: It was conducted an analysis of all the culture results of the nosocomial infections reported by the Sistema de Vigilancia Epidemiológica Hospitalaria (Epidemiological Surveillance System) of the Instituto Mexicano del Seguro Social during the year 2013. The most frequent and relevant microorganisms were reported. RESULTS: 48 377 results from cultures of nosocomial infections were studied. Of these 13 207 (27.3 %) were from 25 high specialty medical units and 35 170 (72.6 %) from 197 second level medical units. The most frequently isolated microorganism was Escherichia coli with 8192 results (16.9 %), followed by the group of Coagulase-negative Staphylococci with 6771 cultures (14 %) and Pseudomonas aeruginosa with 5275 results (19.9 %). Slight differences between levels of care and specialized hospitals were observed. CONCLUSION: This study identifies the Escherichia coli, the group of Coagulase-negative Staphylococci and the Pseudomonas aeruginosa as the main microorganisms to prevent.


Introducción: la prevención y el control de las infecciones nosocomiales requiere el conocimiento del tipo de microorganismo que es más frecuentemente aislado. En México se carece de una estadística nacional que identifique el principal microorganismo causante de infecciones nosocomiales. Métodos: se estudiaron todos los resultados positivos de los cultivos de las infecciones nosocomiales reportadas por el sistema de Vigilancia Epidemiológica Hospitalaria del Instituto Mexicano del Seguro Social durante el año 2013. Se reportaron los microorganismos más frecuentes y los de mayor relevancia epidemiológica. Resultados: se estudiaron 48 377 resultados de cultivos de infecciones nosocomiales; de estos, 13 207 (27.3 %) correspondieron a las 25 unidades médicas de alta especialidad y 35 170 (72.6 %) a las 197 unidades médicas de segundo nivel. El microorganismo más frecuentemente aislado fue la Escherichia coli con 8192 (16.9 %), seguido del grupo de los Staphylococcus coagulasa-negativos con 6771 (14 %) y la Pseudomonas aeruginosa 5275 (19.9 %). Se observaron diferencias ligeras entre los niveles de atención y entre los hospitales monotemáticos. Conclusiones: el presente estudio identifica a la Escherichia coli, a los Staphylococcus coagulasa-negativos y a la Pseudomonas aeruginosa como los principales microorganismos que se deben combatir.


Subject(s)
Candidiasis/epidemiology , Cross Infection/microbiology , Gram-Negative Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/epidemiology , Academies and Institutes , Candidiasis/diagnosis , Candidiasis/prevention & control , Cross Infection/diagnosis , Cross Infection/epidemiology , Cross Infection/prevention & control , Escherichia coli Infections/diagnosis , Escherichia coli Infections/epidemiology , Escherichia coli Infections/prevention & control , Gram-Negative Bacterial Infections/diagnosis , Gram-Negative Bacterial Infections/prevention & control , Gram-Positive Bacterial Infections/diagnosis , Gram-Positive Bacterial Infections/prevention & control , Humans , Infection Control , Mexico/epidemiology , Pseudomonas Infections/diagnosis , Pseudomonas Infections/epidemiology , Pseudomonas Infections/prevention & control , Pseudomonas aeruginosa/isolation & purification , Social Security , Staphylococcal Infections/diagnosis , Staphylococcal Infections/epidemiology , Staphylococcal Infections/prevention & control
3.
BMC Pregnancy Childbirth ; 12: 48, 2012 Jun 12.
Article in English | MEDLINE | ID: mdl-22691696

ABSTRACT

BACKGROUND: Neonatal sepsis is a worldwide public health issue in which, depending on the studied population, marked variations concerning its risk and prognostic factors have been reported. The aim of this study was to assess risk and prognostic factors for neonatal sepsis prevailing at a medical unit in southeastern Mexico. Thus, we used a historic cohort design to assess the association between a series of neonates and their mothers, in addition to hospital evolution features and the risk and prognosis of neonatal sepsis (defined by Pediatric Sepsis Consensus [PSC] criteria) in 11,790 newborns consecutively admitted to a Neonatology Service in Mérida, Mexico, between 2004 and 2007. RESULTS: Sepsis was found in 514 of 11,790 (4.3 %) newborns; 387 of these cases were categorized as early-onset (<72 h) (75.3 %) and 127, as late-onset (>72 h) (24.7 %). After logistic regression, risk factors for sepsis included the following: low birth weight; prematurity; abnormal amniotic fluid; premature membrane rupture (PMR) at >24 h; respiratory complications, and the requirement of assisted ventilation, O(2) Inspiration fraction (IF) >60 %, or a surgical procedure. Some of these factors were differentially associated with early- or late-onset neonatal sepsis. The overall mortality rate of sepsis was 9.5 %. A marked difference in the mortality rate was found between early- and late-onset sepsis (p >0.0001). After Cox analysis, factors associated with mortality in newborns with sepsis comprised the following: prematurity; low birth weight; low Apgar score; perinatal asphyxia, and the requirement of any invasive medical or surgical procedure. CONCLUSIONS: The incidence of neonatal sepsis in southeastern Mexico was 4.3 %. A different risk and prognostic profile between early- and late-onset neonatal sepsis was found.


Subject(s)
Sepsis/epidemiology , Age of Onset , Apgar Score , Birth Weight , Humans , Infant, Newborn , Length of Stay , Logistic Models , Mexico , Prognosis , Respiration, Artificial , Retrospective Studies , Risk Factors , Sepsis/microbiology , Sepsis/mortality
SELECTION OF CITATIONS
SEARCH DETAIL
...